Insights from a Desmoplakin Mutation Identified in Lethal Acantholytic Epidermolysis Bullosa  by Hobbs, Ryan P. et al.
Gilhar A, Paus R, Kalish RS (2007) Lymphocytes,
neuropeptides, and genes involved in alope-
cia areata. J Clin Invest 117:2019–27
Guardiola J, Maffei A (1993) Control of MHC class
II gene expression in autoimmune, infectious,
and neoplastic diseases. Crit Rev Immunol
13:247–68
Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M,
Paus R (2004) Collapse and restoration of
MHC class-I-dependent immune privilege:
exploiting the human hair follicle as a model.
Am J Pathol 164:623–34
Ito T, Ito N, Saatoff M, Hashizume H, Fukamizu
H, Nickoloff BJ et al. (2008) Maintenance of
hair follicle immune privilege is linked to
prevention of NK cell attack. J Invest Derma-
tol 128:1196–206
Krief P, Augery-Bourget Y, Plaisance S, Merck MF,
Assier E, Tanchou V et al. (1994) A new
cytokine (IK) down-regulating HLA class II:
monoclonal antibodies, cloning and chromo-
some localization. Oncogene 9:3449–56
Livak KJ, Schmittgen TD (2001) Analysis of
relative gene expression data using real-time
quantitative PCR and the 2(Delta Delta
C(T)) method. Methods 25:402–8
McDonagh AJ, Snowden JA, Stierle C, Elliott K,
Messenger AG (1993) HLA and ICAM-1 expres-
sion in alopecia areata in vivo and in vitro: the
role of cytokines. Br J Dermatol 129:250–6
McElwee KJ, Hoffmann R, Freyschmidt-Paul P,
Wenzel E, Kissling S, Sundberg JP et al.
(2002) Resistance to alopecia areata in C3H/
HeJ mice is associated with increased
expression of regulatory cytokines and a
failure to recruit CD4+ and CD8+ cells.
J Invest Dermatol 119:1426–33
Paus R, Ito N, Takigawa M, Ito T (2003) The hair
follicle and immune privilege. J Investig
Dermatol Symp Proc 8:188–94
Paus R, Nickoloff BJ, Ito T (2005) A ‘‘hairy’’
privilege. Trends Immunol 26:32–40
Philpott MP, Green MR, Kealey T (1992) Rat hair
follicle growth in vitro. Br J Dermatol
127:600–7
Yu M, Zloty D, Cowan B, Shapiro J, Haegert A,
Bell RH et al. (2008) Superficial, nodular,
and morpheiform basal-cell carcinomas ex-
hibit distinct gene expression profiles. J Invest
Dermatol 128:1797–805
Insights from a Desmoplakin Mutation Identified
in Lethal Acantholytic Epidermolysis Bullosa
Journal of Investigative Dermatology (2010) 130, 2680–2683; doi:10.1038/jid.2010.189; published online 8 July 2010
TO THE EDITOR
By linking tension-bearing intermediate
filaments (IFs) to sites of robust cell–cell
adhesion at desmosomes, desmoplakin
(DP) has an essential role in maintain-
ing integrity of tissues that experience
mechanical stress such as skin and
heart (Green and Simpson, 2007). Two
DP isoforms are present in epithelia,
resulting from alternative splicing of
one gene. The C-terminal IF-binding
domain in each isoform is identical,
containing three plakin-repeat domains
(A, B, and C), separated by flexible
linker regions, and followed by a 68-
residue tail involved in regulating DP-IF
specificity. These motifs cooperate to
anchor IFs to desmosomes (Stappen-
beck et al., 1993; Meng et al., 1997;
Choi et al., 2002; Fontao et al., 2003).
Over 50 mutations have been identi-
fied throughout the desmoplakin gene
(DSP) associated with autosomal-domi-
nant or -recessive disorders affecting the
skin, heart, hair, and nails (http://
www.arvcdatabase.info; Bolling and
Jonkman, 2009). Lethal acantholytic
epidermolysis bullosa (LAEB) is an auto-
somal-recessive disease of severe skin
and mucosal fragility caused by prema-
ture DSP termination. In the first
reported LAEB case, the resultant trun-
cated protein lacked the IF-binding
domain and consequently lost keratin
anchorage at the desmosomal plaque
(Jonkman et al., 2005). The second LAEB
case reported a 5-base pair deletion
causing frameshift and premature termi-
nation in exon 20. No tissue was
available for immunofluorescence or
biochemical analysis so the effect on
protein function is unknown (Bolling
et al., 2010). Here, we describe a
previously unreported DSP mutation
resulting in LAEB without apparent
cardiac involvement. Biochemical ana-
lysis of patient keratinocytes (KCs) sheds
light on possible compensatory mechan-
isms that may allow embryonic survival.
A full-term girl, born to consangui-
neous parents, showed virtually total
denudement of skin (Figure 1a) and
mucosae, absent fingernails and
toenails (Figure 1b), and total alopecia
(Figure 1c). Denuded sites re-epithelia-
lized within days without residual
scarring, but blistering recurred rapidly.
Cardiac echocardiograms and chest
X-rays were normal, but the airway filled
with extensive sloughed mucosa. His-
tological sections revealed suprabasal
acantholysis or cell clusters in a single
acantholytic basal cell layer (arrow,
Figure 1d). Immunofluorescence micro-
scopy revealed staining for all basement
membrane zone markers, with plectin
and cytokeratin staining a discontinu-
ous single row of basal KCs adherent to
the basement membrane. DP staining
was absent (data not shown). Based on
the poor prognosis, the parents with-
drew support and the baby expired
on day 26 from airway obstruction.
Autopsy was refused.
After parental institutional review
board-approved informed consent in
adherence to the Declaration of
Helsinki Principles, mutation screening
was performed on genomic DNA iso-
lated from peripheral blood. The com-
plete genomic DNA coding sequence
of DSP was amplified and directly
sequenced as described (Whittock
et al., 1999). The proband showed a
homozygous single nucleotide deletion
(DSP:c.7248delT) in exon 24, which
was heterozygous in parental genomic
DNA (data not shown).
Consistent with a C-terminal muta-
tion, an anti-DP C-terminal antibody
Abbreviations: DP, desmoplakin; IF, intermediate filament; LAEB, lethal acantholytic epidermolysis
bullosa
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Figure 1. Clinical features of lethal acantholytic epidermolysis bullosa (LAEB) and desmoplakin (DP) schematic highlighting sites of mutations. At birth,
patient had (a) virtually total skin denudement with underlying erythema, (b) absent toenails, and (c) total alopecia. (d) Hematoxylin and eosin (H&E) sections
of a skin biopsy show only a single, discontinuous row of basal keratinocytes (KCs; arrows). (e) Desmoplakin schematic showing gene exons, protein
domains, and protein sites of homozygous or compound heterozygous mutations identified from patients with either LAEB (p.I958LfsX5 (Bolling et al., 2010);
p.R1934X/p.L203GfsX28 (Jonkman et al., 2005)), cardiocutaneous disorders similar to Carvajal/Naxos syndrome (p.K2542SfsX18 (Norgett et al., 2000);
p.R1267X (Uzumcu et al., 2006); p.Q673X/Q1446X (Asimaki et al., 2009); p.G2375R (Alcalai et al., 2003); p.T2104QfsX11/p.A2655D (Mahoney et al., 2010)),
or skin fragility/wooly hair syndrome (p.C809X/N287K, p.Q664X/R2366C (Whittock et al., 2002)). Bar¼ 20mm.
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Figure 2. Immunostaining and biochemical analysis of lethal acantholytic epidermolysis bullosa (LAEB) keratinocytes (KCs). KCs immunostained with
antibodies targeting (a) desmoplakin (DP) N terminus (NW161) or C terminus (NW6), (b) E-cadherin (HECD-1), b-catenin (C2206), or plakoglobin (1407)
(bar¼ 30 mm). Lysates were separated on 7.5% SDS-PAGE gel, transferred to nitrocellulose, and probed using antibodies targeting (c) DP N terminus,
DP C terminus, DP I-specific (DP2.17), plakoglobin, or desmoglein-2 (4B2), (d) and E-cadherin, N-cadherin (Invitrogen, Carlsbad, CA; cat. no. 33-3900), or
fibronectin (Sigma, St Louis, MO; cat. no. F3648). Tubulin (12G10) used as loading control. Primary antibodies listed in parenthesis. (e) Quantitation of DP
mRNA levels based on quantitative real-time RT-PCR analysis from three independent experiments in triplicate. DP primers used were the following: forward
50-ACCAGAACCAGAACACCATC-30 and reverse 50-GGGCAAAACACTCATCCAATTC-30. Error bars derived from standard deviation of Ct values.
P-value determined by unpaired Student’s t-test.
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(NW6), failed to reveal the punctate
pattern characteristic of desmosome
staining at cell–cell interfaces in
cultured patient KCs (Figure 2a).
Surprisingly, an N-terminal antibody
(NW161) only rarely detected faint
DP punctae between cells (Figure 2a).
While the desmosomal cadherin,
desmoglein-2, was absent from inter-
cellular borders (data not shown),
E-cadherin, b-catenin, and plakoglobin
staining were better preserved, consis-
tent with a less-pronounced effect on
adherens junctions (Figure 2b).
DP was undetectable in patient KC
lysates, regardless of antibody domain
specificity, without reduction of other
desmosomal components (Figure 2c).
The identified point mutation predicts
truncation (p.Phe2416LeufsX14) within
plakin-repeat domain B (Figure 1e).
Although quantitative real-time RT-
PCR analysis indicated reduced DSP
transcript levels in patient KCs com-
pared to normal human epidermal
KCs, the difference was not statistically
significant (Figure 2e). These data sup-
port the idea that reduced DP expres-
sion in patient KCs is controlled either
translationally or through degradation
pathways, the latter that was proposed
for a recent case of cutaneous disease
without evidence of heart defects
resulting from virtually complete loss
of plakoglobin in the skin (Cabral et al.,
2010).
Interestingly, LAEB KCs exhibit
reduced E-cadherin and elevated
N-cadherin protein levels compared to
multiple normal human epidermal KCs
isolates of the same passage number
(Figure 2d and Supplementary Figure S1
online). In addition, the extracellular
matrix glycoprotein fibronectin was ele-
vated in LAEB lysates (Figure 2d).
Furthermore, plakoglobin and, to a lesser
extent, b-catenin were observed in the
nucleus of LAEB KCs (Figure 2b), where
they may initiate transcription events
upon the loss of DP expression (Garcia-
Gras et al., 2006). We propose that
elevated N-cadherin and fibronectin
may facilitate re-epithelialization in the
patient’s skin (Clark, 1990; Peinado et al.,
2004), and further speculate that loss of
DP might trigger a ‘‘cadherin switch,’’ a
process that occurs during epithelial–
mesenchymal transition (Nishimura and
Takeichi, 2009), but has not previously
been linked with desmosome molecules.
Although it was not possible to assess
whether similar elevation of N-cadherin
occurred in cardiac tissue, compensation
by this intercalated disc protein might
help counter any potential loss of DP in
the heart.
A consistent genotype–phenotype
correlation linking DSP mutations
to disease has not yet emerged. DP
truncations and/or point mutations
may variably cause cardiac and/or
skin syndromes (Supplementary Table
S1 online). In the cases of LAEB, severe
skin fragility is observed when muta-
tions cause complete loss of DP
C-terminal expression. However, less
severe cases of skin fragility/woolly hair
and palmoplantar keratoderma, with or
without cardiomyopathy, have been
reported in patients when (1) at least
one copy of full-length DP I is expres-
sed, but with a point mutation
(Whittock et al., 2002; Alcalai et al.,
2003; Mahoney et al., 2010); (2) DP I
expression is lost, but at least one
copy of full-length DP II is expressed
(Uzumcu et al., 2006; Asimaki et al.,
2009); or (3) homozygous DP C-termi-
nus truncation occurs downstream of
plakin-repeat domain B (Norgett et al.,
2000). Thus, it seems likely that pre-
sence of at least one full-length copy of
a DP isoform, whether DP I or DP II,
may keep patients from developing
early lethality as seen in LAEB. In
contrast, near-complete loss of DP
(described herein) would be predicted
to result in severe impairment of
both epidermal and cardiac integrity
(Gallicano et al., 2001). In utero survival
and the lack of observed cardiac
involvement in the patient of this study
could reflect compensatory mechanisms
that stabilized adhesion, re-epitheliali-
zation, and cardiac integrity.
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TO THE EDITOR
Cholinergic urticaria (CU) is a sweat-
ing-associated, syringeal orifice-coinci-
dent wheal mediated by acetylcholine.
CU is occasionally associated with
depressed sweating, as reported under
the name of anhidrosis (complete lack
of sweating) or hypohidrosis (incom-
plete lack of sweating) (Itakura et al.,
2000). There have been reported 29
patients with CU with anhidrosis and/or
hypohidrosis (CUAH) (Kay and Maibach,
1969; Itakura et al., 2000; Yoshida
et al., 2009). One hypothesis for the
relationship between the wheal forma-
tion and the depressed sweating is that
the patients are hypersensitive to un-
known substance(s) in their sweat and
develop wheals in response to sweat
leaking from the syringeal ducts to the
dermis possibly by obstruction of the
ducts (Adachi et al., 1994; Kobayashi
et al., 2002). In fact, some patients with
common CU exhibit wheals to intra-
dermal injection of the patients’ own
diluted sweat as well as acetylcholine
and histologically show sweat duct
obstruction (Fukunaga et al., 2005).
However, none of the reported patients
with CUAH were positive to the in-
tradermally injected autologous sweat,
suggesting that ‘‘sweat hypersensitivity’’
is not responsible for CUAH. In addi-
tion, if sweat hypersensitivity is the
mechanism, the anhidrotic area should
be the predilection site for wheal, but
such an observation has not been
reported.
The study design was approved
by the review board of University
of Occupational and Environmental
Health. Measurements in this study
were performed after informed consent
had been obtained. The study was
conducted according to the Declaration
of Helsinki guidelines. To address its
mechanism, we investigated four non-
smoker male CUAH patients, aged 23
(case 1), 24 (case 2), 50 (case 3), and 36
years (case 4). The exercise challenge
and iodine–starch assessment for sweat
induction (Kobayashi et al., 2002)
revealed that the skin surfaces of all
patients were divided into the anhidro-
tic and hypohidrotic areas (Figure 1a).
The skin with normal sweating was not
seen in any patient. As represented by
case 1, the applied iodine–starch was
discolored by sweat in the hypohidrotic
but not anhidrotic area (Figure 1b, left),
and following exercise challenge, the
patients developed pinpoint wheals in
only the hypohidrotic areas (Figure 1b,
right). Intradermal injection of acetyl-
choline yielded wheal with sweating at
only the hypohidrotic areas (Figure 1c).
The injection of autologous sweat or
serum did not produce wheal in either
hypohidrotic or anhidrotic area. Histo-
logically, a periglandular lymphocytic
infiltrate was observed around eccrine
glands in the anhidrotic but not hypo-
hidrotic area of all patients (Figure 1d).
There was no occlusion of sweat ducts.
By immunohistochemistry, the infiltrat-
ing lymphocytes consisted of a mixture
of CD4þ and CD8þ T cells (CD4/CD8
ratio, 1.21; Figure 1e).
Skin sections were immunohisto-
chemically stained with anti-choliner-
gic receptor muscarin 3 (CHRM3)
antibody (H-210, 1:50; Santa Cruz
Biotechnology, Santa Cruz, CA), which
is the most important CHR for sweating
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